JAK2 and non-small cell lung carcinoma: Co‐IP assay revealed an interaction between SH2B1 and IRS1 proteins, as well as between SH2B1 and positive control JAK2 (a known binding partner of SH2B1) in NSCLC cells (Figure S3A).